Justin Holland

Justin Holland

Executive Director, UK Analytical, Analytical Development

Subject Expert
About

Justin Holland has over 20 years of experience in pharmaceutical testing to support all phases of drug product development from pre-clinical through to commercial release. He joined the company in 2009 and oversees the analytical development and quality control teams at the Nottingham site primarily supporting the development of early phase drug products for Phase I clinical trials. 

His expertise includes working with poorly soluble molecules, modified release formulations and paediatric drug products and the associated testing.  

Justin holds a MChem degree in Chemistry from the Nottingham Trent University.

Quotient Sciences Translational Pharmaceutics
Translational Pharmaceutics, Drug Product Optimization, First-in-Human, Human ADME

Translational Pharmaceutics® Integrated Drug Development Info Sheet

10 March 2025 Read More

Latest news from Quotient Sciences

More News
News & Announcements, Nottingham, UK, Artificial Intelligence, Translational Pharmaceutics®, Formulation Development Quotient Sciences and Acesion Pharma Announce Collaboration on AI-Enhanced Formulation Development to Advance Atrial Fibrillation Pipeline By: Dr. Andrew Lewis
Read More
News & Announcements, Artificial Intelligence, Translational Pharmaceutics®, Formulation Development Quotient Sciences shortlisted for "Best Use of AI in Clinical Development & Trial Innovation" at the Scrip Awards 2026 By: Dr. Andrew Lewis
Read More